Celltrion Gets Ready To Face The Competition After European Bevacizumab Nod

Vegzelma CT-P16 Biosimilar Rival To Avastin Receives CHMP Positive Opinion

Europe Map Crowd People
Celltrion faces a crowded European market for bevacizumab • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products